News Roche develops Bundibugyo Ebola test in six days A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of the current outbreak.
News AbbVie's ovarian cancer drug Elahere gets NHS green light AbbVie's Elahere has become the first new NHS therapy in more than 20 years for resistant ovarian cancer, providing an alternative to chemotherapy.
News ASCO26: Symptom-tracking app helps advanced cancer patients An app used to support people living with advanced cancer has helped them maintain quality of life, and also kept them out of hospital.
News DHSC lauds benefits of single patient record ahead of debate The NHS digital single patient record (SPR) could result in 20,000 fewer A&E visits in England per year and save £20m a year, says the UK government.
News Pharmacy First prescribing expanded to ease GP pressure From the autumn, pharmacists in England will be able to prescribe a wider array of medicines under the Pharmacy First programme.
News Review advises against broad NHS prostate cancer screening The UK's National Screening Committee has concluded that the harms of widespread prostate cancer screening would outweigh its benefits.
News Roivant wins FDA approval for first targeted dermatomyositis... Roviant & Priovant Therapeutics finally secure US approval for once-daily oral TYK2/JAK1 inhibitor, Lisraya (brepocitinib), for dermatomyositis.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.